Abstract:
A compound for use as a diagnostic or therapeutic pharmaceutical and method of using the same where the compound consists essentially of an alpha-melanotropin stimulating hormone analog which has integrally located a radionuclide. The radionuclide is administered to the body in an amount sufficient to allow uptake and retention by the tumor cells.
Abstract:
A method of packaging a beverage having gas in solution has an open topped container 1 in which is located a hollow insert 5 having a restricted aperture 12. The container is charged with the beverage such as beer 15 so that the aperture 12 is submerged in the beverage and the container is sealed to form a headspace 19 which is pressurized, preferably by dosing with liquid nitrogen. Following sealing the container is rapidly inverted to locate the aperture 12 in the headspace 19 so that gas pressures in the insert chamber 10 and the headspace 19 come into equilibrium. With the fluid contents in equilibrium, or substantially so, the package is reinverted so that gas under pressure in the insert chamber 10 communicates directly by way of the aperture 12 with beer in the chamber 10. Upon opening of the headspace 19 to atmospheric pressure for dispensing the beer a pressure differential is developed by which gas from the insert chamber 10 is initially ejected through the aperture 12 into the beer 15 to effect in the development of a froth on the beer 15. Beer 30 which may flow into the insert chamber 10 prior to the aperture 12 moving to communication with the headspace 19 is accommodated within a well 13 of the insert chamber 10 remote from the aperture 12 to alleviate the ejection of such beer 30 into the beer 15.
Abstract:
Computer-based industrial control systems and methods employing object oriented hardware elements. An object oriented hardware element may comprise a processor core coupled one side to a universal real-world interface circuit, and on the other side to an open bus interface. In a preferred embodiment, the open bus interface provides downloading software programming objects to the microprocessor core. A computer-based control system in accordance with the present invention may comprise a personal computer or central processing unit coupled to a communications network, at least one zone interface module coupled to the communications network and to an open bus, at least one zone device module coupled to the open bus and, if required, one or more zone processor modules coupled to the open bus. Software object may be downloaded from the personal computer or central processing unit to the various modules to achieve modular, exception-based, distributively intelligent (MEDI) I/O control within the system.
Abstract:
The ErbB-2 receptor, a member of the tyrosine kinase type 1 family of receptors, has been implicated in many human malignancies. Bacteriophage display technology was employed to identify peptides that bound to the extracellular domain of human ErbB-2. The peptide KCCYSL, most frequently occurring in the affinity selected population, was chemically synthesized and characterized for its binding activities to the recombinant extracellular domain of ErbB-2. The synthetic peptide exhibits high specificity to ErbB-2 as well as to ErbB-1, another member of ErbB family. Thus, this peptide can be employed in cancer imaging or therapeutic agent targeting to malignant cells ErbB-2 receptor.
Abstract:
A compound for use as a diagnostic or therapeutic pharmaceutical and method of using the same where the compound consists essentially of an alpha-melanotropin stimulating hormone analog which has integrally located a radionuclide. The radionuclide is administered to the body in an amount sufficient to allow uptake and retention by the tumor cells.
Abstract:
The present invention generally relates to detection of carbohydrate biomarkers in nipple aspirate fluid samples. One aspect of the invention is a method for assaying a nipple aspirate fluid for the presence of TF or Tn carbohydrate biomarker. The assay generally employs an immobilized capture agent specific for TF or Tn and can be further coupled to either direct or indirect detection of bound TF or Tn carbohydrate biomarker through the use of a labeled binding agent.
Abstract:
A compound for use as a diagnostic or therapeutic pharmaceutical and method of using the same where the compound consists essentially of an alpha-melanotropin stimulating hormone analog which has integrally located a radionuclide. The radionuclide is administered to the body in an amount sufficient to allow uptake and retention by the tumor cells.
Abstract:
The ErbB-2 receptor, a member of the tyrosine kinase type 1 family of receptors, has been implicated in many human malignancies. Bacteriophage display technology was employed to identify peptides that bound to the extracellular domain of human ErbB-2. The peptide KCCYSL, most frequently occurring in the affinity selected population, was chemically synthesized and characterized for its binding activities to the recombinant extracellular domain of ErbB-2. The synthetic peptide exhibits high specificity to ErbB-2 as well as to ErbB-1, another member of ErbB family. Thus, this peptide can be employed in cancer imaging or therapeutic agent targeting to malignant cells ErbB-2 receptor.
Abstract:
The ErbB-2 receptor, a member of the tyrosine kinase type 1 family of receptors, has been implicated in many human malignancies. Bacteriophage display technology was employed to identify peptides that bound to the extracellular domain of human ErbB-2. The peptide KCCYSL, most frequently occurring in the affinity selected population, was chemically synthesized and characterized for its binding activities to the recombinant extracellular domain of ErbB-2. The synthetic peptide exhibits high specificity to ErbB-2 as well as to ErbB-1, another member of ErbB family. Thus, this peptide can be employed in cancer imaging or therapeutic agent targeting to malignant cells ErbB-2 receptor.
Abstract:
A liquid dispensing system and a packaging apparatus which includes such a system has a chamber 6 of a chryogenic vessel 2 containing a reservoir of liquid gas 1 (such as nitrogen, oxygen or argon) which is to be dispensed in doses 26 through an outlet port 12 which is in constant communication with a sub-chamber 17. The sub-chamber 17 is part of a piston 16 and cylindr 15 device in which the piston is reciprocated by means 21 and 24 to expand and contract the sub-chamber. When the sub-chamber 17 is expanded, liquid gas enters from the reservoir 1 through flow ports 18 which are closed by the piston 16 during contraction of the sub-chamber to dispense a dose 26.Mounted beneath the outlet port 12 is a tubular skirt having internal passages 30 through which purging gas directed into the region 29 adjacent to the outlet port 12. The region 29 is purged of air to alleviate ice build-up at the outlet port 12. The purging gas liquifies at a temperature not greater than the temperature of the liquid gas at the outlet port and provides a back-pressure at the outlet port to restrain flow of liquid gas therethrough prior to the contraction of the sub-chamber 17 to dispense a dose.The doses 26 are dispensed into open topped containers that are moved successively beneath the outlet port 12 and means 50 is provided for sensing the containers and controlling the devices 21 and 24 to maintain synchronization between the dispensing and the movement of the containers.